Regulatory compliance
The TGA monitors and enforces regulatory compliance in relation to therapeutic goods. This supports consumer protection and a fair market for industry.
Latest alerts
-
We have tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989.
-
African Vigorous Max Strength poses a serious risk to your health and should not be taken.
-
Ziyinzhuangyang tablets pose a serious risk to your health and should not be taken.
Latest articles
-
TGA and InstantScripts reach settlement
The TGA has settled judicial review proceedings brought by InstantScripts in respect of infringement notices issued to it by the TGA. -
Sun Herbal Pty Ltd fined $18,780 for alleged unlawful supply of a complementary medicine
We have issued an infringement notice to the New South Wales based company for the alleged supply of a complementary medicine that was missing a mandatory warning statement. -
New quality standards for MDMA and psilocybine
Two new quality standards, one for MDMA and another for psilocybine, have been published.
Latest publications
-
This fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
-
This plan outlines the compliance and education priorities of the Therapeutic Goods Administration for 2024.
-
Overview of therapeutic goods advertising complaints handling and compliance for 2022-23